Pallas Capital Advisors LLC Buys 11,800 Shares of Bath & Body Works, Inc. $BBWI

Key Points

• Pallas Capital Advisors LLC increased its stake in Bath & Body Works by 45.6%, owning 37,696 shares valued at approximately $1.13 million as of their recent SEC filing.
• Institutional investors and hedge funds now own 95.14% of Bath & Body Works' stock, with notable increases in holdings from firms like Victory Capital Management and AQR Capital Management.
• Bath & Body Works reported earnings per share (EPS) of $0.37, aligning with analysts' expectations, while setting guidance of 3.35-3.60 EPS for FY 2025.

Pallas Capital Advisors LLC raised its stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 45.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 37,696 shares of the company's stock after acquiring an additional 11,800 shares during the quarter. Pallas Capital Advisors LLC's holdings in Bath & Body Works were worth $1,129,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the stock. T. Rowe Price Investment Management Inc. raised its holdings in Bath & Body Works by 7.6% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 11,016,767 shares of the company's stock valued at $334,029,000 after acquiring an additional 781,681 shares during the period. Victory Capital Management Inc. raised its holdings in Bath & Body Works by 14,732.0% in the 1st quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company's stock valued at $206,119,000 after acquiring an additional 6,752,274 shares during the period. Alliancebernstein L.P. raised its holdings in Bath & Body Works by 4.7% in the 1st quarter. Alliancebernstein L.P. now owns 5,422,058 shares of the company's stock valued at $164,397,000 after acquiring an additional 243,611 shares during the period. AQR Capital Management LLC raised its holdings in Bath & Body Works by 267.8% in the 1st quarter. AQR Capital Management LLC now owns 3,993,173 shares of the company's stock valued at $121,073,000 after acquiring an additional 2,907,506 shares during the period. Finally, GMT Capital Corp increased its holdings in shares of Bath & Body Works by 7.3% during the first quarter. GMT Capital Corp now owns 3,737,700 shares of the company's stock worth $113,327,000 after purchasing an additional 255,600 shares during the period. 95.14% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

BBWI has been the topic of several recent research reports. Morgan Stanley lowered their target price on shares of Bath & Body Works from $19.00 to $18.00 and set an "overweight" rating on the stock in a report on Friday, September 12th. The Goldman Sachs Group lowered their target price on shares of Bath & Body Works from $44.00 to $43.00 and set a "buy" rating on the stock in a report on Friday, May 30th. Citigroup lowered their target price on shares of Bath & Body Works from $42.00 to $40.00 and set a "buy" rating on the stock in a report on Tuesday, August 19th. JPMorgan Chase & Co. raised their target price on shares of Bath & Body Works from $40.00 to $46.00 and gave the stock an "overweight" rating in a report on Monday, July 28th. Finally, Barclays increased their price target on shares of Bath & Body Works from $30.00 to $32.00 and gave the stock an "equal weight" rating in a research report on Friday, August 29th. Twelve equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $39.69.

Bath & Body Works Stock Down 4.5%

BBWI traded down $1.18 during midday trading on Friday, hitting $25.11. The company had a trading volume of 10,541,740 shares, compared to its average volume of 7,282,604. Bath & Body Works, Inc. has a 52 week low of $24.93 and a 52 week high of $41.87. The company has a market capitalization of $5.18 billion, a price-to-earnings ratio of 7.45, a PEG ratio of 0.86 and a beta of 1.49. The stock's 50 day moving average price is $29.58 and its 200 day moving average price is $29.77.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings results on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, meeting the consensus estimate of $0.37. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The firm had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.55 billion. During the same period in the previous year, the firm posted $0.37 earnings per share. The business's revenue was down .8% compared to the same quarter last year. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. Research analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, September 5th. Investors of record on Friday, August 22nd were issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 3.2%. The ex-dividend date of this dividend was Friday, August 22nd. Bath & Body Works's dividend payout ratio is 23.74%.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.